missing translation for 'onlineSavingsMsg'
Learn More

CD27/TNFRSF7 Antibody (rLPFS2/8837), Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-23943-100ug

 View more versions of this product

Product Code. 18660764

  • € 462.00 / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD27/TNFRSF7 Monoclonal antibody specifically detects CD27/TNFRSF7 in Human samples. It is validated for Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD27/TNFRSF7
Monoclonal
0.2 mg/mL
Immunohistochemistry-Paraffin : 1-2 μg/mL
CD27 antigen, CD27 molecule, MGC20393, S152CD27L receptor, T cell activation antigen CD27, T cell activation antigen S152, T14, TNFRSF7T-cell activation antigen CD27, Tp55, Tumor necrosis factor receptor superfamily member 7, tumor necrosis factor receptor superfamily, member 7
Recombinant human CD27/TNFRSF7 protein fragment (aa 28-170) (exact sequence is proprietary)
100 μg
Adaptive Immunity, Apoptosis, B Cell Development and Differentiation Markers, Cancer, Hematopoietic Stem Cell Markers, Immunology, Innate Immunity, Stem Cells
939
Store at 4°C.
IgG1 κ
Immunohistochemistry (Paraffin)
rLPFS2/8837
Unconjugated
10 mM PBS with 0.05% BSA
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.